This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
SHEEP ANTI HUMAN NFkB p65
catalog :
AHP394
quantity :
0.1 mg
clonality :
polyclonal
host :
domestic sheep
conjugate :
nonconjugated
reactivity :
human
application :
western blot, ELISA, immunoprecipitation, EMSA
product information
Entity Category :
Antibodies
Product Code :
AHP394
Description :
SHEEP ANTI HUMAN NFkB p65
Specificity :
NFkB p65
Target Species :
Human
Host :
Sheep
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
E, GS, IP, WB
Application Types :
ELISA, Western Blotting, Immunoprecipitation, Gel Super Shift Assays
Quantity :
0.1 mg
Quantity Value :
0.1 mg
Quantity Type :
mg
GO Accessions :
GO:0002755, GO:0002756, GO:0003682, GO:0003705, GO:0005829, GO:0005667, GO:0006916, GO:0006954, GO:0006968, GO:0008063, GO:0042802, GO:0010224, GO:0010843, GO:0016563, GO:0016564, GO:0019221, GO:0019901, GO:0031293, GO:0031625, GO:0032582, GO:0033613, GO:0034130, GO:0034134, GO:0034138, GO:0034142, GO:0042301, GO:0043123, GO:0044419, GO:0045087, GO:0045944, GO:0047485, GO:0048011, GO:0050727, GO:0050852, GO:0051059, GO:0051092, GO:0051607, GO:0070431, GO:0070491, GO:0070555
GO Terms :
activation of I-kappaB kinase/NF-kappaB cascade, activation of NF-kappaB, activation of NF-kappaB transcription factor, activation of transcription from RNA polymerase II promoter, amino-terminal binding, amino-terminus binding, antiviral response, apoptosis inhibitor activity, cellular defence response, cytokine and chemokine mediated signaling pathway, cytokine mediated signalling pathway, defence response to virus, defense response to viruses, DNA binding, transcription promoter, down regulation of gene-specific transcription, down-regulation of gene-specific transcription, downregulation of gene-specific transcription, GO:0001107, GO:0002226, GO:0003710, GO:0016066, GO:0016067, inhibition of gene-specific transcription, interaction with another species, interspecies interaction, interspecies interaction with other organisms, isoform-specific homophilic binding, lamin/chromatin binding, membrane protein solubilization, microtubule/chromatin interaction, MyD88-dependent TLR signaling pathway, MyD88-dependent toll-like receptor signalling pathway, MyD88-independent TLR signaling pathway, MyD88-independent toll-like receptor signalling pathway, negative transcriptional regulator activity, nerve growth factor receptor signalling pathway, NF-kappaB activation, NGF receptor signaling pathway, NGF receptor signalling pathway, NH2-terminal binding, NH2-terminus binding, NOD2 signaling pathway, nonspecific immune response, N-terminal binding, N-terminal end binding, nuclear membrane vesicle binding to chromatin, nucleotide-binding oligomerization domain containing 2 signalling pathway, positive regulation of transcription from Pol II promoter, protein homopolymerization, response to IL-1, response to medium wave ultraviolet light stimulus, response to medium wave ultraviolet radiation stimulus, response to UVB light stimulus, response to UV-B light stimulus, response to UVB radiation stimulus, response to UV-B radiation stimulus, stimulation of I-kappaB kinase/NF-kappaB cascade, stimulation of transcription from RNA polymerase II promoter, T lymphocyte receptor signaling pathway, T lymphocyte receptor signalling pathway, T-cell receptor signaling pathway, T-cell receptor signalling pathway, TCR signaling pathway, Tl signaling pathway, Tl signalling pathway, TLR1 signaling pathway, TLR2 signaling pathway, TLR3 signaling pathway, TLR4 signaling pathway, T-lymphocyte receptor signaling pathway, T-lymphocyte receptor signalling pathway, Toll signalling pathway, toll-like receptor 1 signalling pathway, toll-like receptor 2 signalling pathway, toll-like receptor 3 signalling pathway, toll-like receptor 4 signalling pathway, transcription activating factor, transcription activator binding, transcriptional activator activity, transcriptional repressor activity, ubiquitin ligase binding, up regulation of I-kappaB kinase/NF-kappaB cascade, up regulation of transcription from RNA polymerase II promoter, up-regulation of I-kappaB kinase/NF-kappaB cascade, upregulation of I-kappaB kinase/NF-kappaB cascade, upregulation of transcription from RNA polymerase II promoter, up-regulation of transcription from RNA polymerase II promoter
Uniprot Accessions :
Q04206
Gene :
RELA
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5970
EntityFormats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0 mg/ml
Product Form :
Purified IgG - liquid
PrimarySecondary :
Primary
NotForSaleInCountries :
Canada
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
questions and comments